978 related articles for article (PubMed ID: 16784312)
1. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
2. Anti-interferon auto-antibodies in autoimmune polyendocrinopathy syndrome type 1.
Levin M
PLoS Med; 2006 Jul; 3(7):e292. PubMed ID: 16756392
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).
Ströbel P; Murumägi A; Klein R; Luster M; Lahti M; Krohn K; Schalke B; Nix W; Gold R; Rieckmann P; Toyka K; Burek C; Rosenwald A; Müller-Hermelink HK; Pujoll-Borrell R; Meager A; Willcox N; Peterson P; Marx A
J Pathol; 2007 Apr; 211(5):563-571. PubMed ID: 17334980
[TBL] [Abstract][Full Text] [Related]
5. Hypothetical review: thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes.
Meager A; Peterson P; Willcox N
Clin Exp Immunol; 2008 Oct; 154(1):141-51. PubMed ID: 18727623
[TBL] [Abstract][Full Text] [Related]
6. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
[TBL] [Abstract][Full Text] [Related]
7. Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications.
Kisand K; Lilic D; Casanova JL; Peterson P; Meager A; Willcox N
Eur J Immunol; 2011 Jun; 41(6):1517-27. PubMed ID: 21574164
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.
Wolff AS; Erichsen MM; Meager A; Magitta NF; Myhre AG; Bollerslev J; Fougner KJ; Lima K; Knappskog PM; Husebye ES
J Clin Endocrinol Metab; 2007 Feb; 92(2):595-603. PubMed ID: 17118990
[TBL] [Abstract][Full Text] [Related]
9. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis.
Meager A; Wadhwa M; Dilger P; Bird C; Thorpe R; Newsom-Davis J; Willcox N
Clin Exp Immunol; 2003 Apr; 132(1):128-36. PubMed ID: 12653847
[TBL] [Abstract][Full Text] [Related]
10. Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice.
Kärner J; Meager A; Laan M; Maslovskaja J; Pihlap M; Remm A; Juronen E; Wolff AS; Husebye ES; Podkrajšek KT; Bratanic N; Battelino T; Willcox N; Peterson P; Kisand K
Clin Exp Immunol; 2013 Mar; 171(3):263-72. PubMed ID: 23379432
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.
Meloni A; Willcox N; Meager A; Atzeni M; Wolff AS; Husebye ES; Furcas M; Rosatelli MC; Cao A; Congia M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1114-24. PubMed ID: 22344197
[TBL] [Abstract][Full Text] [Related]
12. The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centers.
Weiler FG; Peterson P; Costa-Carvalho BT; de Barros Dorna M; Correia-Deur JE; Sader SL; Espíndola-Antunes D; Guerra-Junior G; Dias-da-Silva MR; Lazaretti-Castro M
Clin Immunol; 2018 Dec; 197():231-238. PubMed ID: 30287219
[TBL] [Abstract][Full Text] [Related]
13. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups.
Hapnes L; Willcox N; Oftedal BE; Owe JF; Gilhus NE; Meager A; Husebye ES; Wolff AS
J Clin Immunol; 2012 Apr; 32(2):230-7. PubMed ID: 22127461
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
[TBL] [Abstract][Full Text] [Related]
15. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.
Kisand K; Bøe Wolff AS; Podkrajsek KT; Tserel L; Link M; Kisand KV; Ersvaer E; Perheentupa J; Erichsen MM; Bratanic N; Meloni A; Cetani F; Perniola R; Ergun-Longmire B; Maclaren N; Krohn KJ; Pura M; Schalke B; Ströbel P; Leite MI; Battelino T; Husebye ES; Peterson P; Willcox N; Meager A
J Exp Med; 2010 Feb; 207(2):299-308. PubMed ID: 20123959
[TBL] [Abstract][Full Text] [Related]
16. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay.
Larosa MDP; Mackenzie R; Burne P; Garelli S; Barollo S; Masiero S; Rubin B; Chen S; Furmaniak J; Betterle C; Smith BR
Clin Chem Lab Med; 2017 Jun; 55(7):1003-1012. PubMed ID: 28099118
[TBL] [Abstract][Full Text] [Related]
17. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.
Wolff AS; Sarkadi AK; Maródi L; Kärner J; Orlova E; Oftedal BE; Kisand K; Oláh E; Meloni A; Myhre AG; Husebye ES; Motaghedi R; Perheentupa J; Peterson P; Willcox N; Meager A
J Clin Immunol; 2013 Nov; 33(8):1341-8. PubMed ID: 24158785
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.
Sarkadi AK; Taskó S; Csorba G; Tóth B; Erdős M; Maródi L
J Clin Immunol; 2014 Feb; 34(2):181-93. PubMed ID: 24493573
[TBL] [Abstract][Full Text] [Related]
19. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes.
Kisand K; Link M; Wolff AS; Meager A; Tserel L; Org T; Murumägi A; Uibo R; Willcox N; Trebusak Podkrajsek K; Battelino T; Lobell A; Kämpe O; Lima K; Meloni A; Ergun-Longmire B; Maclaren NK; Perheentupa J; Krohn KJ; Scott HS; Husebye ES; Peterson P
Blood; 2008 Oct; 112(7):2657-66. PubMed ID: 18606876
[TBL] [Abstract][Full Text] [Related]
20. A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1.
Zhang L; Barker JM; Babu S; Su M; Stenerson M; Cheng M; Shum A; Zamir E; Badolato R; Law A; Eisenbarth GS; Anderson MS
Clin Immunol; 2007 Nov; 125(2):131-7. PubMed ID: 17825626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
